Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer Stage IIIA|Breast Cancer, Stage IIIB|Breast Cancer Stage IV
Interventions: DRUG: 1% Glycated Chitosan|DEVICE: Photothermal Laser|DRUG: Placebo|DRUG: Cyclophosphamide|DRUG: Standard of Care
Sponsor: Eske Corporation S.A.C